Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Sektor | Ocena Analityków |
---|---|---|---|---|---|---|---|---|---|---|---|
CSJCSL LTD | 80.11 B CHF | 163.973 CHF | −0.03% | 5 | 0.04 | 36.43 | 4.50 CHF | −0.85% | 1.37% | Technologie medyczne | Kup |
0QFMODERNA INC | 38.059 B CHF | 99.920 CHF | +6.29% | 9 | 0.11 | — | −10.44 CHF | −156.54% | 0.00% | Technologie medyczne | Kup |
22UABIONTECH SE DR | 19.123 B CHF | 81.401 CHF | +1.11% | 2 | 0.03 | 23.58 | 3.45 CHF | −90.50% | 0.00% | Technologie medyczne | Kup |
BM8BIOMARIN PHARMA | 15.805 B CHF | 80.909 CHF | +2.86% | 100 | 0.86 | 83.85 | 0.96 CHF | +183.32% | 0.00% | Technologie medyczne | Kup |
1CGCRISPR THERAPEUTIC | 4.314 B CHF | 52.283 CHF | −0.30% | 30 | 0.23 | — | −1.66 CHF | +78.56% | 0.00% | Technologie medyczne | Kup |
MORMORPHOSYS | 2.495 B CHF | 66.110 CHF | +0.60% | 100 | 0.78 | — | −5.34 CHF | −21.86% | 0.00% | Technologie medyczne | Neutralnie |
PPGNPOLYPEPTIDE N | 971.119 M CHF | 28.85 CHF | −1.87% | 17.393 K | 0.59 | — | −1.52 CHF | −198.61% | 0.00% | Technologie medyczne | Neutralnie |
LWBMESOBLAST LTD | 621.598 M CHF | 0.501 CHF | — | 2 K | — | — | — | — | 0.00% | Technologie medyczne | Silne kup |
8EMEDITAS MEDICINE IN | 401.764 M CHF | 4.895 CHF | −47.52% | 3 K | 28.96 | — | −1.73 CHF | +41.62% | 0.00% | Technologie medyczne | Kup |
AXD2HERON THERAPEUTICS | 363.789 M CHF | 2.724 CHF | — | 2.74 K | — | — | −0.73 CHF | +53.89% | 0.00% | Technologie medyczne | Silne kup |
KURNKUROS N | 235.291 M CHF | 6.89 CHF | +2.38% | 201.239 K | 0.72 | — | −0.38 CHF | −63.13% | 0.00% | Technologie medyczne | Silne kup |
4XBXBIOTECH INC | 224.407 M CHF | 7.249 CHF | −17.57% | 450 | 0.51 | — | −0.68 CHF | +32.19% | 0.00% | Technologie medyczne | — |
6MLMOLECULAR PARTNERS | 118.563 M CHF | 3.403 CHF | −6.64% | 500 | 0.82 | — | −1.89 CHF | −152.70% | 0.00% | Technologie medyczne | Neutralnie |
MOLNMOLECULAR PARTNERS N | 118.563 M CHF | 3.200 CHF | −1.84% | 20.118 K | 2.35 | — | −1.89 CHF | −152.70% | 0.00% | Technologie medyczne | Neutralnie |